Caleco Pharma Corp.

103 East Holly Street
Bellingham, WA 98225 USA
Click for website

Research Sector

Summary Description Research and development company with focus on prescription biopharmaceuticals and direct-to-consumer nutritional supplements.

Management Harry H.S. Fong, Ph.D., Advisor for Product and Intellectual Property Development, Professor Emeritus of Pharmacognosy Dept. of Medicinal Chemistry and Pharmacognosy University of Illinois at Chicago; Jim Metropoulos, MD, Advisor for Product Development and Marketing; Bob Adler, Advisor for Product Development and Marketing

Click here for Financial Data
Keywords: biopharmaceuticals, nutritional supplements, plant extracts, probiotics, Lamiridosin, food supplements, oral, liver, synthetic derivatives, semi-synthetic derivatives, poly-pharmaceutical, psoriasis, acne, dermatitis


Updated: Jun. 22, 2010


Caleco Pharma Corp. is a unique healthcare products research and development company with divisions focused on prescription biopharmaceuticals and direct-to-consumer nutritional supplements. The commo......view more

Products / Services

Our proprietary Lamiridosin-based plant extracts exhibit anti-viral and anti-inflammatory properties making them ideal candidates for multiple formulations targeting chronic conditions. Collectively ......view more

Technology / Differentiation

Our lead products are both based on a proprietary Liver Health formulation targeting the global hepatitis C prescription market - an $8 Billion market - and the liver health maintenance market via a n...view more

Market / Customers

The pharmaceutical markets in which we have early stage developmental compounds totals more than $10 billion dollars. The global nutrition supplement industry is a $228 billion colossus. We are in ac......view more


The Company is pursuing funding to provide working capital to complete our in-license payment for 2010, complete our pre-clinical Liver Health Formulation derivative research program, initiate clinica...view more